122 related articles for article (PubMed ID: 18161112)
1. [Biochemical markers for bone turnover: Serum beta-CTX].
Ichimura S; Iwamoto J
Nihon Rinsho; 2007 Nov; 65 Suppl 9():237-44. PubMed ID: 18161112
[No Abstract] [Full Text] [Related]
2. [Biochemical markers of bone turnover: Serum P1NP].
Imanishi Y; Nishizawa Y
Nihon Rinsho; 2007 Nov; 65 Suppl 9():231-5. PubMed ID: 18161111
[No Abstract] [Full Text] [Related]
3. Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study.
Garnero P; Cloos P; Sornay-Rendu E; Qvist P; Delmas PD
J Bone Miner Res; 2002 May; 17(5):826-33. PubMed ID: 12009013
[TBL] [Abstract][Full Text] [Related]
4. [Serum beta-CTx(beta-CrossLaps)].
Okabe R
Nihon Rinsho; 2004 Feb; 62 Suppl 2():369-72. PubMed ID: 15035154
[No Abstract] [Full Text] [Related]
5. [Effects of SERMs on bone health. The evaluation of raloxifene treatment for elderly women with osteoporosis using bone turnover markers].
Hasegawa M; Ichimura S; Satomi K
Clin Calcium; 2010 Mar; 20(3):413-20. PubMed ID: 20190372
[TBL] [Abstract][Full Text] [Related]
6. Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover.
Delmas PD; Licata AA; Reginster JY; Crans GG; Chen P; Misurski DA; Wagman RB; Mitlak BH
Bone; 2006 Aug; 39(2):237-43. PubMed ID: 16563890
[TBL] [Abstract][Full Text] [Related]
7. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis.
Vlasiadis KZ; Damilakis J; Velegrakis GA; Skouteris CA; Fragouli I; Goumenou A; Matalliotakis J; Koumantakis EE
Maturitas; 2008 Mar; 59(3):226-33. PubMed ID: 18342460
[TBL] [Abstract][Full Text] [Related]
8. [Biochemical markers of bone remodeling: recent data of their applications in managing postmenopausal osteoporosis].
Bahlous A; Kalai E; Hadj Salah M; Bouzid K; Zerelli L
Tunis Med; 2006 Nov; 84(11):751-7. PubMed ID: 17294906
[TBL] [Abstract][Full Text] [Related]
9. [N-terminal crosslinking telopeptide of type I collagen].
Fukunaga M
Nihon Rinsho; 2004 Dec; 62 Suppl 12():236-9. PubMed ID: 15658308
[No Abstract] [Full Text] [Related]
10. Evaluation of ability of biochemical markers of bone turnover to predict a response to increased doses of HRT.
Rosen HN; Parker RA; Greenspan SL; Iloputaife ID; Bookman L; Chapin D; Perlmutter I; Kessel B; Qvist P; Rosenblatt M
Calcif Tissue Int; 2004 May; 74(5):415-23. PubMed ID: 14961215
[TBL] [Abstract][Full Text] [Related]
11. Urinary bone resorption markers (deoxypyridinoline and C-terminal telopeptide of type I collagen) in healthy persons, postmenopausal osteoporosis and patients with type I diabetes.
Fassbender WJ; Gödde M; Brandenburg VM; Usadel KH; Stumpf UC
Adv Med Sci; 2009; 54(1):1-6. PubMed ID: 19482729
[TBL] [Abstract][Full Text] [Related]
12. The effect of raloxifene on markers of bone turnover in older women living in long-term care facilities.
Hansdóttir H; Franzson L; Prestwood K; Sigurdsson G
J Am Geriatr Soc; 2004 May; 52(5):779-83. PubMed ID: 15086661
[TBL] [Abstract][Full Text] [Related]
13. Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis.
Chen P; Satterwhite JH; Licata AA; Lewiecki EM; Sipos AA; Misurski DM; Wagman RB
J Bone Miner Res; 2005 Jun; 20(6):962-70. PubMed ID: 15883636
[TBL] [Abstract][Full Text] [Related]
14. [Type I collagen crosslinked C-telopeptides].
Hoshino H; Kushida K
Nihon Rinsho; 2004 Feb; 62 Suppl 2():365-8. PubMed ID: 15035153
[No Abstract] [Full Text] [Related]
15. Guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004).
Nishizawa Y; Nakamura T; Ohta H; Kushida K; Gorai I; Shiraki M; Fukunaga M; Hosoi T; Miki T; Chaki O; Ichimura S; Nakatsuka K; Miura M;
J Bone Miner Metab; 2005; 23(2):97-104. PubMed ID: 15750686
[No Abstract] [Full Text] [Related]
16. [Evaluation of therapeutic intervention on bone mass and turnover through monitoring of biochemical markers of bone turnover].
Ohta H
Nihon Rinsho; 2006 Sep; 64(9):1663-9. PubMed ID: 16972676
[TBL] [Abstract][Full Text] [Related]
17. The circulating concentration and ratio of total and high molecular weight adiponectin in post-menopausal women with and without osteoporosis and its association with body mass index and biochemical markers of bone metabolism.
Sodi R; Hazell MJ; Durham BH; Rees C; Ranganath LR; Fraser WD
Clin Biochem; 2009 Sep; 42(13-14):1375-80. PubMed ID: 19523465
[TBL] [Abstract][Full Text] [Related]
18. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats.
DeLaurier A; Jackson B; Pfeiffer D; Ingham K; Horton MA; Price JS
Res Vet Sci; 2004 Aug; 77(1):29-39. PubMed ID: 15120950
[TBL] [Abstract][Full Text] [Related]
19. Serum cathepsin K as a marker of bone metabolism in postmenopausal women treated with alendronate.
Muñoz-Torres M; Reyes-García R; Mezquita-Raya P; Fernández-García D; Alonso G; Luna Jde D; Ruiz-Requena ME; Escobar-Jiménez F
Maturitas; 2009 Nov; 64(3):188-92. PubMed ID: 19819089
[TBL] [Abstract][Full Text] [Related]
20. [Effect of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis].
Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harpe K
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):269-73. PubMed ID: 15059505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
